Andrew Kelly PhD
About Andrew Kelly PhD
Andrew Kelly, PhD, is the MS&T Upstream Associate Director at Bristol Myers Squibb in Dublin, Ireland, with a background in materials science and extensive experience in manufacturing and engineering roles across various companies.
Current Role at Bristol Myers Squibb
Andrew Kelly PhD currently holds the position of MS&T Upstream Associate Director at Bristol Myers Squibb in Dublin, Ireland. In this role, he is responsible for overseeing upstream manufacturing processes and ensuring adherence to regulatory standards. His work involves leading strategic initiatives aimed at optimizing production efficiency and maintaining product quality.
Previous Positions at Bristol Myers Squibb
Before his current role, Andrew Kelly has held multiple positions at Bristol Myers Squibb. Between 2018 and 2020, he worked as a Manufacturing Technology Manager, focusing on technology integration and process improvement. From 2016 to 2018, he served as an MS&T Material Science Lead, where he managed materials science projects and contributed to product development initiatives.
Experience at Pfizer and Johnson & Johnson
Prior to his tenure at Bristol Myers Squibb, Andrew Kelly PhD worked at Pfizer as a Supply Base Manager for eight months in 2016, based in Ireland. Additionally, he spent a total of nearly two years at DePuy Synthes Companies of Johnson & Johnson. He first served as a Materials Engineer from 2014 to 2015 in Ringaskiddy, Cork, and then as a Staff Engineer from 2015 to 2016, focusing on engineering materials and staff management.
Education and Academic Background
Andrew Kelly holds a Doctor of Philosophy (PhD) in Materials Science from Cranfield University, where he studied from 2011 to 2014. He also earned a Master of Science (MSc) in Manufacturing Engineering from Trinity College Dublin, completing his studies from 2009 to 2011. Prior to that, he earned a degree in Engineering with Management from the same institution, studying from 2005 to 2009.
Technical Skills and Contributions
Andrew Kelly PhD has developed a novel, patentable colloidal processed ceramic for use in high-volume sensor manufacturing. He leads lean manufacturing and continuous improvement projects within a portfolio valued at $100M. His expertise includes a comprehensive working knowledge of quality systems such as ISO 13485 and 21 CFR Part 820, ensuring compliance and enhancing manufacturing efficiencies.